Vaso SG&A Expenses 2010-2024 | VASO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Vaso sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$202.3B
Intuitive Surgical (ISRG)	$191.3B
Edwards Lifesciences (EW)	$44.5B
Alcon (ALC)	$42.5B
IQVIA Holdings (IQV)	$36.3B
IDEXX Laboratories (IDXX)	$33.9B
DexCom (DXCM)	$31.3B
Waters (WAT)	$22.2B
STERIS (STE)	$20.6B
SONOVA HOLDING (SONVY)	$19.8B
Hologic (HOLX)	$16.5B
Fresenius Medical Care AG KGaA (FMS)	$13.3B
Sysmex ADR (SSMXY)	$11.7B
Globus Medical (GMED)	$11.4B
Penumbra (PEN)	$9.2B
Masimo (MASI)	$9B
Glaukos (GKOS)	$8.3B
Teleflex (TFX)	$8.2B
Integer Holdings (ITGR)	$4.5B
PROCEPT BioRobotics (PRCT)	$4.4B
Veracyte (VCYT)	$3.2B
Inari Medical (NARI)	$3.1B
LivaNova (LIVN)	$2.5B
Tandem Diabetes Care (TNDM)	$2.4B
Nihon Kohden (NHNKY)	$2.4B
TransMedics (TMDX)	$2.1B
Elekta AB (EKTAY)	$2B
Integra LifeSciences Holdings (IART)	$1.7B
RxSight (RXST)	$1.4B
Alphatec Holdings (ATEC)	$1.3B